ArticleFrontiers in pharmacology2024

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database.

Ya-Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.